Dublin, Ireland · Founded 2016 · Privately Held (backing)
Developer of an anti-aging therapeutics designed to extend healthy lifespan by targeting core aging mechanisms. Juvenescence is based in Dublin, Ireland and was founded in 2016. Its last reported valuation was $502 million in Aug 2019. It has raised $341 million across 4 recorded rounds; the latest was a $9.4 million early-stage round in Dec 2020.
Last reported valuation
$502.0M
Oct 2026
Priced at
—
Total raised
$340.7M
Last round
Early Stage VC
Dec 2020
Cap table — not yet on record
Juvenescence's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Juvenescence with a free account
·The complete investor list: 18 names
·Watch Juvenescence: the Monday email on marks, rounds and moves